Introduction
Breast cancer is the most common malignancy among women in North America and approximately one-third of these women develop metastases and die (Jemal et al., 2006) . Dysregulation of normal mechanisms of apoptosis play an important role in the pathogenesis and progression of breast cancer. Importantly, the efficacy of chemotherapy can be compromised by the survival signals that tumor cells receive (Krajewski et al., 1999) .
There is a strong association of autotaxin (ATX) expression with breast cancer cell survival, growth, migration, invasion and metastasis (Nam et al., 2000 (Nam et al., , 2001 Umezu-Goto et al., 2002; Yang et al., 2002; Hama et al., 2004) . ATX was originally isolated from human melanoma A2058 cells (Stracke et al., 1992) and it generates lysophosphatidate (LPA) from circulating lysophosphatidylcholine (LPC). Although the involvement of LPA and ATX in the invasiveness of breast cancer has been studied (Yang et al., 2002) , relatively little is known about how ATX might confer chemoresistance. First, the substrate of ATX, LPC, has been postulated to be an extracellular signaling lipid by acting on G2A and GPR4 Zhu et al., 2001; Rikitake et al., 2002; Lin and Ye, 2003; Radu et al., 2004; Kim et al., 2005) . Unsaturated LPC is secreted by the liver (Brindley, 1993) and saturated LPC is produced by circulating lecithin:cholesterol acyltransferase in high-density lipoproteins (Aoki et al., 2002) . LPC is present in blood at up to 200 mM (Moolenaar et al., 2004) . ATX could, therefore, regulate cell activation through changing signaling by LPC versus LPA. Secondly, ATX decreases the adhesion of oligodendrocytes to the extracelllular matrix through a non-catalytic mechanism involving its C-terminus, and this facilitates morphological remodeling (Dennis et al., 2005) . This suggests that ATX is a matrix-cellular protein that signals through integrin-dependent focal adhesion assembly and consequently cell interactions with the extracellular matrix (Fox et al., 2004) . This and other non-catalytic effects of ATX could contribute to its association with the aggressiveness of cancer cells.
Autotaxin provides a major route for generating extracellular LPA, which is present at up to 20 mM in blood and extracellular fluid (Moolenaar et al., 2004; Yue et al., 2004) . LPA is produced by activated platelets to facilitate wound healing and is secreted by cancer cells (Fang et al., 2000; Radeff-Huang et al., 2004) . Extracellular LPA has been implicated in the etiology of human cancer, as it stimulates cell growth, proliferation, differentiation, motility and survival (Mills and Moolenaar, 2003; Brindley, 2004) . Diverse actions of LPA are mediated by at least six G-protein coupled receptors present on the cell surface: LPA 1 /EDG2, LPA 2 /EDG4, LPA 3 /EDG7, LPA 4 /GPR23/p2y9, LPA 5 / GRP92 and LPA 6 /p2y5 (Lee et al., 2006; Pasternack et al., 2008) . The expression of these receptors is cell specific, enabling different cells to respond in a unique manner through signaling pathways that are activated by G i , G s , G q and G 12/13 . These signaling cascades include phosphatidylinositol 3-kinase (PI3K) and Akt, the extracellular signal-regulated kinase (ERK) pathway, and the small G-protein, RhoA, that mediates cell survival (Ye et al., 2002; Tigyi and Parrill, 2003; RadeffHuang et al., 2004) . Activation of LPA receptors also decreases the abundance of the p53 tumor suppressor, thereby promoting cell survival and cell cycle progression (Murph et al., 2007) .
Lysophosphatidate levels are high in ascites fluid and plasma of patients with ovarian tumors (Xu et al., 1998; Fang et al., 2002; Mills and Moolenaar, 2003) . LPA promotes ovarian tumor development through increased cyclin D expression (Chappell et al., 2001) . LPA also increases vascular endothelial growth factor production, which stimulates angiogenesis (So et al., 2005) . In a colon cancer cell line, LPA increases the synthesis of macrophage migration inhibitory factor, which promotes tumor growth (Sun et al., 2003) . However, the effect of LPA on cell survival and apoptosis varies among cell types. LPA mediates survival of ovarian cancer cells, macrophages, fibroblasts and neonatal cardiac myocytes, while promoting apoptosis in hippocampal neurons and PC12 cells (Fang et al., 2002; Ye et al., 2002) .
Taxol is a microtubule-stabilizing agent that interferes with spindle microtubule dynamics causing cell cycle arrest and apoptosis through interaction with b-tubulin (Bergstralh and Ting, 2006) . This causes lateral polymerization and microtubule stability (Snyder et al., 2001) . Taxol is widely used for treating metastatic and early-stage breast cancer, with benefits in overall and disease-free survival. However, resistance to Taxol is common and there is a need to identify patients who will respond to treatment (McGrogan et al., 2008) .
In this study, we established that ATX protects MCF-7 breast cancer cells and MDA-MB-435 melanoma cells against Taxol-induced apoptosis through its production of LPA from the LPC that bathes most cells. LPA is strongly antagonistic to Taxol-induced apoptosis, whereas LPC has no significant effect. From our results, we predict that identifying patients who express high ATX activity and then inhibiting this activity could provide an important adjuvant for improving the efficacy of Taxol in cancer treatment.
Results
Expression of ATX in MCF-7 and MDA-MB-435 cancer cells ATX expression in the MCF-7 and MDA-MB-435 cells used in our experiments was compared. Real-time reverse transcriptase-PCR (RT-PCR) analysis showed that MDA-MB-435 cells expressed relatively high levels of ATX mRNA compared with MCF-7 cells (Figure 1a ). MDA-MB-435 cells secreted ATX protein into the serum-free medium, whereas ATX was not detectable in the equivalent medium concentrated from MCF-7 cells (Figure 1b) . ATX activity secreted by MDA-MB-435 cells was about 24 times higher (Po0.001) than that from MCF-7 cells (Figure 1c) . Therefore, MCF-7 cells provide a system for studying apoptosis in the absence of ATX and for examining the effects of introducing ATX.
LPA protects MCF-7 cells from Taxol-induced apoptosis
We next established conditions for studying Taxolinduced apoptosis and how LPC and LPA modify this Lysophosphatidate inhibits Taxol-induced apoptosis N Samadi et al process. Apoptosis was detected both by morphological examination using 4,6-diamidino-2-phenylindole (DAPI) staining and by measuring mitochondrial tetramethlyrhodamine ethyl ester (TMRE) uptake. We used medium supplemented with 10% charcoal-treated fetal bovine serum (FBS) to remove lipid mediators including LPC and LPA. This treatment also removed ATX, as we could not detect significant ATX activity in media containing 10% charcoal-treated FBS (results not shown).
Treating MCF-7 cells with 50 nM Taxol produced an optimum increase in the percentage of recovered apoptotic nuclei from 0.8% to about 12% after 24 h and 26% after 48 h (Figure 2a) , and a similar effect was observed with MDA-MB-435 cells (results not shown). This provides part of the picture, as treatment with 50 nM Taxol for 24 and 48 h decreased the number of cells attached to the dishes by about 60 and 70%, respectively ( Figure 2b ). We could not recover most of these cells from the medium presumably because of complete fragmentation. These results are compatible with those of Sunders et al. (1997) , who concluded that Taxol induces both apoptotic and nonapoptotic death in MCF-7 cells.
The next experiments determined whether LPA can protect against apoptosis induced by 50 nM Taxol over 24 h. LPA (0.5 mM) alone had no significant effect on the percentage of apoptotic nuclei, but it produced a maximum decrease in the percentage of apoptotic cells remaining on the plates in the presence of Taxol. Less effect was observed at 5 and 10 mM LPA (Figure 2c ). However, 0.5-10 mM LPA increased the recovery of viable cells from 49 ± 4.3 to 68 ± 6.1% (Figure 2d) .
The second method used flow cytometry to detect apoptotic cells by TMRE-negative staining. Optimum apoptosis in the recovered cells was detected at 20 nM Taxol and this increased from 24 to 48 h (Figure 3a) . We chose to use 48 h incubations, which increased the population of apoptotic cells to about 55%. LPA (5-20 mM) had a significant protective effect against different concentrations of Taxol. Maximum protection was obtained with 5 mM LPA against 20 nM Taxol in which the percentage of apoptotic cells decreased (Po0.05) from 54 ± 2 to 33 ± 3% (Figure 3b ).
Isobologram analysis was used to evaluate the interactions between Taxol and LPA at the IC 50 (inhibitory concentration 50%). All LPA concentrations used produced an antagonistic effect on Taxol-induced apoptosis with combination index values of >1 (Table 1) . This antagonism was particularly apparent at 10 and 20 mM LPA (Po0.01). For example, 50 nM Taxol was required when 20 mM LPA was present to produce equivalent apoptosis to that obtained with Concentrated medium from MDA-MB-435 cells supplemented with 10 mM LPC decreased percentage apoptosis measured by DAPI staining from 7.4 ± 1.3% to 4.4 ± 0.6% (88% of the effect of 0.5 mM LPA) ( Figure 4a ). The percentage of viable cells recovered also increased (49 ± 3% to 77 ± 7%; Po0.05) (Figure 4b ). Concentrated medium from MDA-MB-435 cells appeared to decrease apoptosis (6.1±0.8%) in the absence of added LPC or LPA, but this was not statistically significant. LPC in the absence of conditioned medium had no protective effect ( Figure 4a ).
We also used an ATX inhibitor, VPC8a202 (Cui et al., 2007) , to determine whether the effect of concentrated medium depended upon ATX activity. VPC8a202 (1 mM) decreased ATX activity by 87% as expected (results not shown) and it abolished the protective effect of LPC plus concentrated media from MDA-MB-435 cells (Figure 4a ). There was no increase in the percentage of viable cells after applying the ATX inhibitor alone (Figure 4b ).
The TMRE assay also showed a significant decrease in apoptosis (Po0.01) in cells treated with concentrated medium from MDA-MB-435 cells when 200 mM LPC was added (Figure 4c ). Concentrated medium alone or LPC alone had no significant protective effect (Figure 4c ). VPC8a202 (1 mM) abolished the protective effect of concentrated media with LPC. As a control, the effect of VPC8a202 was shown to be specific, as it did not alter the protective effect of LPA on Taxol-induced apoptosis (Figures 4b and c) .
To confirm that the effects of concentrated medium cells depended on ATX activity, we used recombinant ATX, which protected against Taxol-induced apoptosis and increased the number of viable cells recovered when LPC was present (Figures 4d and e) . Blocking ATX activity with 1 mM of the inhibitors VPC8a202, or S32826 (Ferry et al., 2008) , or heating at 70 1C abolished the protective effect of recombinant ATX. Furthermore, concentrated medium from MCF-7 cells that contained no significant ATX activity failed to provide any significant protection with LPC against Taxol-induced apoptosis (Figures 5a-c) .
We also showed that the endogenous ATX produced by MDA-MB-435 cells protects these cells against Taxol-induced apoptosis when LPC is present, as this effect is blocked by the ATX inhibitors, VPC8a202 or S32826 (Figure 6 ). The inhibitors had no effect of the protection afforded by LPA.
LPA protects against Taxol-induced apoptosis by increasing PI3K/Akt and decreasing ceramide production We examined the roles of the PI3K-Akt and MAPK/ ERK kinase-ERK pathways on apoptosis by using LY294002 and PD98059, respectively. LY294002 (50 mM) almost completely abrogated the effects of LPA in protecting against apoptosis (Figures 7a  and b) . PD98059 (40 mM) showed no significant effect on the LPA protection against Taxol-induced apoptosis, although it blocked the activation of p42/44 mitogenactivated protein kinase (MAPK) (Figures 8a-c) . Also, phospho-42/44p MAPK and total 42/44p MAPK showed a significant increase over 12 h in response to LPA. There was no significant effect of Taxol alone on the expression of phospho-42/44p MAPK and total 42/44p MAPK.
Lysophosphatidate (5 mM) increased (Po0.05) the expression of both phospho-Akt and total Akt by about twofold over 12 h (Figure 8a ) and the ratio of phospho-Akt/total Akt (Figure 8d ). Taxol (30 nM) alone had no significant effect. When Taxol was added with LPA (5 mM), there was still a 50% increase in phosphoAkt and total Akt compared with nontreated cells (Figure 8a ) and an increase in the phospho-Akt/total Akt ratio (Figure 8d ). Applying 50 mM LY294002 abolished the effect of LPA on the elevation of activated and total Akt.
To determine the protective mechanism of LPA against Taxol-induced apoptosis, we measured ceramide mass. There was a 2.9-fold increase in ceramide accumulation in Taxol-treated cells (Po0.05) after 24 h of incubation. LPA (0.5 mM) decreased (Po0.05) the Taxol-induced increase in ceramides to 1.9-fold. LY294002 (50 mM) blocked the effect of LPA in decreasing ceramide accumulation by about 80% (Figure 9 ).
Interactions of LPA versus Taxol on the cell cycle Taxol-induced apoptosis is accompanied by increased accumulation of cells in the G2/M phase of the cell cycle (McGrogan et al., 2008) . Under our conditions, this represented an increase from about 16 to 43% (Po0.05) (Figures 10a and c) , which is compatible with previous studies (Spankuch et al., 2007; Demidenko et al., 2008) . The dose-response interactions between different concentrations of Taxol and LPA in Figure 3b were assessed by isobologram analysis.
Lysophosphatidate inhibits Taxol-induced apoptosis N Samadi et al
Adding 5 mM LPA decreased the cells in G2/M to 28% and this represented reversal of the Taxol-induced effect of about 44% (Po0.05) (Figures 10c and d) . Adding LY294002 blocked most of the LPA effect in reducing (Po0.05) the cells trapped in G2/M in the presence of Taxol (Figures 10d and h ). As controls, we showed that 50 nM LY294002 or 5 mM LPA alone or in combination had no significant effect on the cells in G2/M phase ( Figures 10b, e and f) . These results demonstrated the dominant role of the PI3K pathway in LPA protection against Taxol-induced apoptosis.
Discussion
Effective chemotherapy depends on successful induction of apoptosis and defects in apoptotic signaling are a major cause of drug resistance (Melet et al., 2008) .
Chemotherapeutic resistance results in poor responses and reduced overall survival in patients with metastatic breast cancer (McGrogan et al., 2008) . We used doses of Taxol, LPA and LPC up to 50 nM, 20 mM and 200 mM, respectively, with MCF-7 cells. These Taxol concentrations are used for the treatment of breast cancer patients (Marchetti et al., 2002) , and the LPA and LPC concentrations are compatible with those in the circulation and tumor microenvironment (Moolenaar et al., 2004; Yue et al., 2004) . We showed that Taxol-induced killing is strongly antagonized by LPA on the basis of measurement of nuclear fragmentation, loss of mitochondrial potential and the recovery of viable cells. LPA (0.5 mM) partially blocked the Taxolinduced increase in the percentage of apoptotic nuclei, but we needed 5 mM LPA to antagonize the effect of 
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Taxol in increasing the proportion TMRE-negative cells. The discrepancies suggest that cells that were protected at low LPA concentrations, where no differences in TMRE staining were observed, probably died by a mitochondria-independent and nonapoptotic (necrotic) mechanism. However, another major factor is that the DAPI and TMRE measurements determine only what happened to cells remaining on the dishes. We, therefore, do not have information concerning the mechanisms of cell death of more than 50% of cells that were not recovered. Consequently, it is significant that 0.5-10 mM LPA increased the number of cells that were recovered after Taxol treatment and that were then reflected in the percentage of apoptotic cells recorded in the DAPI and TMRE staining assays. Accumulating evidence shows that LPA promotes survival of ovarian cancer cells (Frankel and Mills, 1996; Goetzl et al., 1999a) , renal proximal tubular cells (Levine et al., 1997) , lymphoblastoma T cells (Goetzl et al., 1999b) , macrophages (Koh et al., 1998) , neonatal Schwann cells (Weiner and Chun, 1999) , fibroblast (Fang et al., 2000) , mesangial cells (Inoue et al., 2001) and colon cancer cells (Rusovici et al., 2007) by preventing apoptosis. Different cell types express different LPA receptors, which have specific roles, and hence the effects of LPA signaling vary from cell to cell. In contrast to the survival role of LPA 1 in Schwann cells (Weiner and Chun, 1999; Contos et al., 2000) , overexpression of LPA 1 in ovarian cancer cells induced apoptosis and anoikis (Furui et al., 1999) , whereas LPA 2 appeared to mediate LPA-stimulated survival of ovarian cancer cells (Goetzl et al., 1999a) . In T lymphoblasts, both LPA 1 and LPA 2 promoted LPA-induced survival (Goetzl et al., 1999a) . LPA also prevents apoptosis in colon cancer cells through LPA 2 receptor (Rusovici et al., 2007) .
LPA 2 is the predominant LPA receptor in MCF-7 cells (Chen et al., 2007) . This is compatible with our finding that 1 mM VPC51299 (an LPA 1/3 receptor antagonist) failed to block the LPA protection against 
Taxol-induced apoptosis in MCF-7 cells (results not shown). Unfortunately, no effective specific agonist for LPA 2 receptors has been developed.
Activation of PI3K-Akt protects primary lymphocytic leukemia cells, ovarian cancer cells and intestinal epithelial cells from apoptosis, whereas G i -mediated activation of ERK is necessary for the survival of fibroblasts (Fang et al., 2000; Gauthier et al., 2001; Baudhuin et al., 2002; Dufour et al., 2004; Harnois et al., 2004; Hu et al., 2005) . In this study, inhibition of PI3K blocked the protective effect of LPA on Taxolinduced apoptosis, whereas blocking ERK activation with PD98059 was without any effect.
Lysophosphatidylcholine is present in plasma and serum at >100 mM in a predominantly albumin-bound form (Croset et al., 2000) and it is also detected in media from tumor cells (Umezu-Goto et al., 2002) . However, in our work, LPC alone did not antagonize Taxolinduced apoptosis unless concentrated medium from MDA-MB-435 cells or recombinant ATX was added. This protective effect was blocked by VPC8a202 and S32826, two ATX inhibitors (Cui et al., 2007; Ferry et al., 2008) , or by heat inactivation of ATX activity. The MDA-MB-435 medium, compared with that produced by MCF-7 cells, contained abundant ATX. Our work establishes that LPC is inactive in protecting against Taxol-induced apoptosis unless it is converted to LPA by ATX. We also showed in our unpublished work that LPC only stimulates the migration of MDA-MB-231 breast cancer cells in the presence of active ATX. These conclusions are compatible with the view that the putative LPC receptors, G2A and GPR4, are protonsensing receptors whose activity is negatively regulated by LPC (Tomura et al., 2005) . Many reported biological effects of LPC are probably mediated through ATX and LPA production.
In vivo, ATX might also hydrolyze sphingosylphosphorylcholine to sphingosine 1-phosphate (Clair et al., 2003) . LPA and sphingosine 1-phosphate show overlapping biological activities on cell survival by acting on distinct receptor families. However, the physiological significance of ATX in producing sphingosine 1-phosphate is not established.
Binding of Taxol to microtubules aberrantly engages the mitotic checkpoint, effecting sustained mitotic arrest (McGrogan et al., 2008) . Ceramide levels regulate sustained mitotic arrest, apoptosis and mitotic slippage (Asakuma, 2003) , and elevated ceramide concentrations are a known component of Taxol-mediated cell death (Charles et al., 2001; Sietsma et al., 2002; Swanton et al., 2007) . Sustained ceramide elevation in the endoplasmic reticulum coordinately activates the stress responses and inactivates anti-apoptotic Akt, thus leading to apoptosis (Swanton et al., 2007) . We showed that LPA attenuated the Taxol-induced increase in ceramides and subsequent apoptosis through PI3K/Akt activation.
In conclusion, our work demonstrates that the abundant extracellular lipid, LPC, protects MCF-7 breast cancer cells and MDA-MD-435 melanoma cells against Taxol-induced apoptosis, but only after its conversion to LPA by ATX. LPA itself showed strong antagonism against the apoptotic effects of Taxol. This work identifies that inhibition of ATX activity could improve the treatment of cancers by Taxol and possibly other chemotherapeutic agents in patients who express high ATX activity. It is, therefore, hoped that biologically stable ATX inhibitors will be developed to test this hypothesis in vivo.
Materials and methods

Materials
RPMI1640 medium, penicillin and streptomycin were obtained from GIBCO (Carlsbad, CA, USA). Trypsin-ethylenediaminetetraacetic acid, TMRE, goat anti-mouse IgG, ATX primers and superscript II reverse transcriptase were obtained from Invitrogen (Carlsbad, CA, USA). DAG kinase, PD98059 and dithiothreitol were obtained from EMD Chemicals Inc. (Gibbstown, NJ, USA). Fatty acid-free bovine serum albumin, paclitaxel (Taxol), activated charcoal (Norit), Hoechst33258, ATP, diethylenetriaminepentaacetic acid (DETAPEC), pertussis toxin, oleoyl-L-a-lysophosphatidic acid, sodium salt (LPA), oleoyl-L-a-LPC, ceramide and monoclonal anti-GAPDH were purchased from Sigma-Aldrich (Oakville, ON, Canada). VPC51299 and VPC8a202 were provided by Drs KR Lynch and TL Macdonald (University of Virginia, Charlottesville, VA, USA 
Cell culture
The MCF-7 and MDA-MB-435 cells were obtained from the American Type Culture Collection. Cells were maintained in RPMI1640 medium with 10% FBS and 1% penicillin/ streptomycin in a humidified atmosphere with 5% CO 2 at 37 1C.
Quantification of apoptotic nuclei using DAPI stain MCF-7 cells (2 Â 10 4 cells/well) were grown in 96-well plates. Cells (about 70% confluent) were washed with phosphatebuffered saline and treated in serum-free media for 24 h. Cells were then fixed in 4% paraformaldehyde for 20 min and permeabilized in 0.1% Triton X-100 for 15 min. Fixed cells were stained with 1 mg/ml Hoechst33258 for 15 min after evaporation of the fixing solution. Nuclear morphology of the cells was observed by fluorescence microscopy. Triplicate samples were prepared for each treatment and at least 300 cells were counted in random fields for each sample and apoptotic nuclei were identified (Sakashita et al., 2007) .
Measurement of LPA breakdown
Six-well plates were seeded with 2 Â 10 5 cells and these were grown to 70% confluence. The half-life of LPA was determined after adding 2 ml of medium containing 32 P-labeled LPA (100,000 d.p.m.) with 1 or 20 mM nonradioactive LPA and measuring 32 P i -and 32 P-labeled LPA during 24 h (Pilquil et al., 2006) . The half-life of LPA was about 10 h and this was independent of the LPA concentration (results not shown). show the western blot analyses for phospho-and total Akt, phospho-and total ERK (p42 and p44 MAPK) and glyceraldehyde phosphate dehydrogenase (GAPDH), which was used as a loading control. The results are representative of three independent experiments and they were quantified by densitometric analysis using a Licor Imaging System. (b) The densitometric ratio of phospho-p42MAPK/total p42MAPK is shown; (c) phosphop44MAPK/total p44MAPK ratio is shown and in (d), phosphoAkt/total Akt is shown. The results are shown as means ± s.e.m. of three independent experiments. *Indicates the difference (Po0.05) from the nontreated cells. Lysophosphatidate inhibits Taxol-induced apoptosis N Samadi et al were grown to confluence in six-well plates over 48 h in RPMI1640 medium with 10% FBS. The medium was changed to RPMI1640 medium with 10% of charcoal-treated FBS. This removed >95% of the LPA as assessed after adding 32 Plabeled LPA to the FBS (results not shown). Cells were incubated for an additional 48 h with LPA-depleted FBS with Taxol, or LPA as indicated. LPA concentrations were maintained by adding half of the original concentration of LPA every 10 h on the basis of the calculated half-life of LPA. Cells were then tripsinized, collected in 96 V-bottomed plate and exposed to TMRE (500 nM) for 30 min at 37 1C. Excess dye was removed with phosphate-buffered saline containing 0.1% fatty acid-free BSA and cell-associated fluorescence was measured with a Calibur Flow Cytometer (Becton Dickinson, San Jose´, CA, USA) using Cell Quest software (Ramjaun et al., 2007) .
Mitochondrial membrane potential (TMRE) assay
ATX expression mRNA expression Total RNA was extracted using the RNAqueous kit, according the manufacture's instruction. DNA-free kit was also applied to remove contaminating DNA from RNA preparation. Total RNA was treated with Lysophosphatidate inhibits Taxol-induced apoptosis N Samadi et al superscript II reverse transcriptase. Real-time RT-PCR was performed with 25 ml of master mix containing 2 Â Syber Green buffer mix and forward and reverse primers (Invitrogen). The internal control was the constitutively expressed housekeeping human glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Primers for human ATX were as follows: sense, 5 0 -ACAACGAGGAGAGCTGCAAT-3 0 ; antisense, 5 0 -AGAAGTCCAGGCTGGTGAGA-3; and for human GAPDH were as follows: sense, 5 0 -ACAGTCAGCCGCATC TTCTT-3 0 ; antisense, 5 0 -GACAAGCTTCCCGTTCTCAG-3 0 . Samples were assayed in triplicate on the 7500 Real Time PCR System (Applied Biosystems).
Western blot analysis Serum-free medium from MD-MB-435 cells was concentrated to 200 ml per 10 6 cells by centrifugation using a Centricon Millipore's Ultracel YM cellulose membrane (Millipore Corporation, Bedford, TX, USA) and analysed using 10% SDS-polyacrylamide gel electrophoresis. Nitrocellulose membranes were treated with Odyssey blocking buffer for 24 h and incubated with 1:5000 dilution of ATX antibody for 60 min followed by four washes with phosphate-buffered saline þ 0.1% Tween-20. Blots were incubated in 1:10 000 dilution of goat anti-rabbit IgG for 45 min. After washing four times, ATX was visualized at 800 nm with the Odyssey Infrared Scanner.
ATX activity assay ATX activity was assayed in 96-well plates using 1 mM FS-3 as a substrate. Fluorescence was read at 15 min intervals by a Synergy2 system (BioTek, Winooski, VT, USA) with excitation and emission wavelengths of 485 and 538 nm, respectively.
Ceramide mass assay Cells (1 Â 10 6 ) were plated in 10 cm culture dishes and grown to confluence in RPMI1640 medium with 10% FBS. After 48 h, the medium was changed to RPMI1640 medium with 10% of charcoal-treated FBS, and cells were incubated for 48 h with the indicated concentrations of Taxol, LPA and LY294002. After washing with phosphate-buffered saline, cell lysates were collected in methanol and the lipids were extracted (Martin et al., 1997) . Ceramide concentrations were measured by conversion to ceramide 1-phosphate, using the diacylglycerol kinase and [g-32 P]ATP and by comparison to standards of ceramide. Results were normalized to the phospholipid concentration of the extract (Martin et al., 1997) .
Statistical analysis and determination of the interaction of Taxol with LPA on apoptosis The interaction was evaluated by the isobologram technique (CalcuSyn software, Biosoft, Cambridge, UK). The experimental iso-effect points were the concentrations (relative to IC 50 concentrations) of the two agents that when combined kill 50% of the cells. A quantitative index of these interactions was provided by the isobologram equation combination index ¼ (a/A) þ (b/B), where A and B represent the Taxol and LPA concentrations that alone produce a fixed level of inhibition (IC 50 ), a and b represent the concentrations required for the same effect when they were combined. CI values of o1 indicate synergy; 1 represents addition and 41 indicate antagonism.
Statistical analysis was performed by analysis of variance with a Kruskal-Wallis post hoc test.
Abbreviations ATX, autotaxin; DAPI, 4,6-diamidino-2-phenylindole; FBS, fetal bovine serum; LPA, lysophosphatidate; LPC, lysophosphatidylcholine; MAPK, mitogen-activated protein kinase; PI3K, phosphatidylinositol 3-kinase; TMRE, tetramethlyrhodamine ethyl ester.
